http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03004008-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a512947babef01615f9a644d796cc1ad
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
filingDate 2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa784e4b9ea1caa70d76221e2829d74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea2f2bbb7ba2ecd031d0e2bea6525f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994c2ddbdb97a805d818ac8b4c58f0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9c95ad5414ad0bdd31765b79c1ed12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb6d97ddf98bcfe016cbced6c83542c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad6d5981fae65940659cc5ace63e3f0a
publicationDate 2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03004008-A2
titleOfInvention Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate
abstract The object of the present invention is a pharmaceutical composition for oral use, in the form of hard gelatin capsules, which contains an excipient from the triglyceride class, for example atomized glyceryl palmitostearate, with double role, of lubricant and binder. The composition is used for the treatment and prophylaxis of calcium metabolism disorders, such as bone resorbtion, hypercalcemia and osteoporosis and contains as active ingredient a derivate of bisphosphonic acid, for example disodium clodronate. The active ingredient disodium clodronate tetrahydrate, granulated by fluidized bed method, is released from the preparation in a proportion of at least 75 % during the first 5 minutes and at least 95 % in 30 minutes.
priorityDate 2001-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9513054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0275468-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID405383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129381420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415958069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449373544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408184029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454095055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261

Total number of triples: 58.